Loading company…
Shanghai Bailong Biotechnology develops AI-enabled drug discovery and precision oncology therapies.
Based in Shanghai, China, Shanghai Bailong Biotechnology develops drugs using artificial intelligence and biotechnology. Founded in 2019, it has a precision oncology pipeline focused on CDKs and synthetic tumor lethality and is developing CDK therapies with Exscientia. It also works with WuXi AppTec and Pharmaron.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in